HLS Therapeutics partners with Esperion Therapeutics to commercialize Nexletol and Nexlizet in Canada: Toronto Friday, May 9, 2025, 14:00 Hrs [IST] HLS Therapeutics Inc. (HLS), a ...

CASI Pharma receives notice from Nasdaq regarding minimum market value requirement: Beijing, China Friday, May 9, 2025, 13:30 Hrs [IST] CASI Pharmaceuticals, Inc, a biopharmaceuti ...

Govt of Telangana appoints Shahnawaz Qasim, director general of the drug control administration ...

FY25 revenue at Rs. 4,454 crore up by 15%, net profit at Rs 344 crore: Our Bureau, Bengaluru Friday, May 9, 2025, 12:30 Hrs [IST] Biocon in its consolidated financial re ...

Major mass photometry milestone achieved by Refeyn with installation of 500 system globally: Oxford, UK Friday, May 9, 2025, 13:00 Hrs [IST] Refeyn, the company behind pioneering ...

GeneFab, RegCell partner to advance autoimmune cell therapy into US clinical trials: Alameda, California Friday, May 9, 2025, 12:00 Hrs [IST] GeneFab, a next-generation cell and g ...

Agilent inaugurates India Solution Centre to accelerate innovation and expand the frontiers of science: Our Bureau, Mumbai ...

Johnson & Johnson Medtech partners with Qure.ai to boost early detection of lung cancer in India: Our Bureau, Mumbai Thursday ...

India’s No. 1 pharma company by revenues and prescriptions has launched its corporate brand campaign that highlights its ...

A non-invasive breast cancer screening test, Revealia Breast offers glimpse to future of early cancer detection: Miami, Florida Friday, May 9, 2025, 11:00 Hrs [IST] Enterprises, I ...

More patients in the linerixibat group had clinically meaningful itch improvement (WI-NRS =3-point reduction) with 56% versus 43% in the placebo group at week 24 (treatment difference 13% [95% CI ...

Rahway, New Jersey Friday, May 9, 2025, 09:00 Hrs [IST] ...